News/ News/ R&D/ Rare diseases/ Transversal Categories Shionogi’s Mulpleta gets FDA green light for patients with liver disease Joy Persaud FDA approval, lusutrombopag, Shionogi, thrombocytopenia 0 Comment The US drug regulator has approved Mulpleta (lusutrombopag) as a treatment for thrombocytopenia in certain patients with chronic Share X Shionogi’s Mulpleta gets FDA green light for patients with liver disease https://pharmaphorum.com/news/shionogis-mulpleta-gets-fda-green-light-for-patients-with-liver-disease/
FDA approval, lusutrombopag, Shionogi, thrombocytopenia
0 Comment
